Pacira BioSciences Reports Second Quarter 2025 Financial Results GlobeNewswire August 05, 2025 — Solid execution across corporate, clinical and commercial initiatives — — Several key milestones advance 5×30 path to growth — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the […]

WOOF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Petco Health and Wellness Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire August 05, 2025 NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that

Comscore Reports Second Quarter 2025 Results GlobeNewswire August 05, 2025 RESTON, Va., Aug. 05, 2025 (GLOBE NEWSWIRE) — Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating media across platforms, today reported financial results for the quarter ended June 30, 2025. “Our execution through the first half of the year has been

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress GlobeNewswire August 05, 2025 OJEMDA(TM) (tovorafenib) net product revenue of $33.6 million in Q2 2025, a 10% quarter-over-quarter increase OJEMDA full-year 2025 net product revenue expected to be $140 to $150 million Ended the second quarter with $453.1 million in cash, cash equivalents and

NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire August 05, 2025 NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action

Jushi Holdings Inc. Reports Second Quarter 2025 Financial Results GlobeNewswire August 05, 2025 Revenue of $65.0 million, Reflecting Year-over-Year and Sequential Growth Net Loss of $12.3 million, Compared to $17.0 million in the First Quarter of 2025 Adjusted EBITDA Increased 39.6% Quarter-over-Quarter to $13.7 million, Up From $9.8 million in Q1 2025 Retail Expansion Plan

IRBT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that iRobot Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire August 05, 2025 NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025 GlobeNewswire August 05, 2025 NEWTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer's disease,

LINE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lineage, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire August 05, 2025 NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit

AAPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Apple Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire August 05, 2025 NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit